International Journal of Radiation Oncology * Biology * Physics
Volume 62, Issue 2 , Pages 386-391 , 1 June 2005

Is a reduction in radiation lung volume and dose necessary with paclitaxel chemotherapy for node-positive breast cancer?

Received 4 June 2004 ,Revised 16 September 2004 ,Accepted 22 September 2004.

References 

  1. Early Breast Cancer Trialists℉ Collaborative Group . Polychemotherapy for early breast cancer (an overview of the randomised trials) . Lancet . 1998;352:930–942
  2. Henderson IC , Berry DA , Demetri GD , et al.   Improved outcomes from adding sequential paclitaxel but not from escalating doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer . J Clin Oncol . 2003;21:976–983
  3. Adjuvant Therapy for Breast Cancer. NIH Consensus Statement Online November 1–3, 2000; 17:1–23. http://consensus.nih.gov/cons/114/114_statement.htm.
  4. Liebmann J , Cook JA , Fisher J , et al.   In vitro studies of Taxol as a radiation sensitizer in human tumor cells . J Natl Cancer Inst . 1994;86:441–446
  5. Milross CG , Mason KA , Hunter NR , et al.   Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel . J Natl Cancer Inst . 1996;88:1308–1314
  6. Milas L , Hunter NR , Kurdoglu B , et al.   Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with Taxol . Cancer Chemother Pharmacol . 1995;35:297–303
  7. Milas L , Hunter N , Mason KA , et al.   Tumor reoxygenation as a mechanism of Taxol-induced enhancement of tumor radioresponse . Acta Oncol . 1995;34:409–412
  8. Taghian AG , Abi-Raad R , Assaad SI , et al.   Paclitaxel decreases the interstitial fluid pressure and improves oxygenation in breast cancers in patients treated with neoadjuvant chemotherapy (Clinical implications) . J Clin Oncol . 2005; in press.
  9. Mason KA , Milas L , Peters LJ . Effect of paclitaxel (Taxol) alone and in combination with radiation on the gastrointestinal mucosa . Int J Radiat Oncol Biol Phys . 1995;32:1381–1389
  10. Milross CG , Mason KA , Hunter NR , et al.   Enhanced radioresponse of paclitaxel-sensitive and -resistant tumours in vivo . Eur J Cancer . 1997;33:1299–1308
  11. Lingos TI , Recht A , Vicini F , et al.   Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy . Int J Radiat Oncol Biol Phys . 1991;21:355–360
  12. Pierce SM , Recht A , Lingos TI , et al.   Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early-stage breast cancer . Int J Radiat Oncol Biol Phys . 1992;23:915–923
  13. Rothwell RI , Kelly SA , Joslin CA . Radiation pneumonitis in patients treated for breast cancer . Radiother Oncol . 1985;4:9–14
  14. Taghian AG , Assaad SI , Niemierko A , et al.   Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel . J Natl Cancer Inst . 2001;93:1806–1811
  15. Hanna YM , Baglan KL , Stromberg JS , et al.   Acute and subacute toxicity associated with concurrent adjuvant radiation therapy and paclitaxel in primary breast cancer therapy . Breast J . 2002;8:149–153
  16. Winer EP , Burstein H , Galper S , et al.   Prospective Phase I evaluation of concurrent paclitaxel and breast radiation therapy following adjuvant doxorubicin/cyclophosphamide chemotherapy for state II/III breast cancer . [Abstract] Proc Am Soc Clin Oncol . 2001; abstract 152.
  17. Bellon JR , Lindsley KL , Ellis GK , et al.   Concurrent radiation therapy and paclitaxel or docetaxel chemotherapy in high-risk breast cancer . Int J Radiat Oncol Biol Phys . 2000;48:393–397
  18. Formenti SC , Symmans WF , Volm M , et al.   Concurrent paclitaxel and radiation therapy for breast cancer . Semin Radiat Oncol . 1999;9:34–42
  19. Yee TK , Whitman GJ , Thames HD , et al.   Clinically relevant pneumonitis after sequential paclitaxel-based chemotherapy and radiotherapy in breast cancer patients . J Natl Cancer Inst . 2004;96:1676–1681
  20. Byhardt RW , Martin L , Pajak TF , et al.   The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small-cell lung cancer (NSCLC)—Analysis of a Radiation Therapy Oncology Group (RTOG) protocol . Int J Radiat Oncol Biol Phys . 1993;27:537–544
  21. Das IJ , Cheng EC , Freedman G , et al.   Lung and heart dose volume analyses with CT simulator in radiation treatment of breast cancer . Int J Radiat Oncol Biol Phys . 1998;42:11–19
  22. Finney DJ . Probit analysis . 3rd ed.. Cambridge, UK: Cambridge University Press; 1971;
  23. Kwa SL , Lebesque JV , Theuws JC , et al.   Radiation pneumonitis as a function of mean lung dose (An analysis of pooled data of 540 patients) . Int J Radiat Oncol Biol Phys . 1998;42:1–9
  24. Emami B , Lyman J , Brown A , et al.   Tolerance of normal tissue to therapeutic irradiation . Int J Radiat Oncol Biol Phys . 1991;21:109–122
  25. Gross NJ . Pulmonary effects of radiation therapy . Ann Intern Med . 1977;86:81–92

 Supported in part by a grant from Massachusetts Department of Public Health, The NCI/AVON Supplement to NCI SPORE award, P50 CA 89393, and Grants CA 50628 and CA 21239 from the National Cancer Institute, Department of Health and Human Services.

PII: S0360-3016(04)02696-3

doi: 10.1016/j.ijrobp.2004.09.044

International Journal of Radiation Oncology * Biology * Physics
Volume 62, Issue 2 , Pages 386-391 , 1 June 2005

Article Tools